About this episode

The episode discusses a groundbreaking gene therapy trial aimed at reversing ageing in retinal cells to improve sight.

The first person has been treated with a highly anticipated new gene therapy that aims to turn back the clock on ageing cells. The trial is aimed at retinal cells, with the hope that encouraging them to behave as if they were young again could improve sight in the affected patients. If it proves to be safe, it could open the door to a whole raft of therapies based on the emerging field of cellular rejuvenation. To understand more about this cutting edge research, Madeleine Finlay hears from science editor Ian Sample and from Paul Knoepfler, professor of cell biology and human anatomy at the university of California, Davis.. Help support our independent journalism at theguardian.com/sciencepod

People in this episode

Host: Madeleine Finlay

Guests: Ian Sample, Paul Knoepfler

Topics covered

• gene therapy
• ageing
• cellular rejuvenation
• retinal cells
• sight improvement

Keywords

• gene therapy
• ageing
• retinal cells
• cellular rejuvenation
• sight improvement

Mentioned in this episode

Organizations: University of California, Davis

More episodes of Science Weekly

• Revisited: A Scottish tea mystery, episode one – green shoots · July 21, 2026 · 22 min
• Fungi: the invisible force protecting our planet · July 14, 2026 · 16 min
• Is male testosterone in freefall? · July 9, 2026 · 14 min
• ‘A break from scrolling’: how Gen Z fell in love with birding · July 7, 2026 · 17 min
• ‘Beautiful blobs’: can scientists build life from scratch? · July 2, 2026 · 17 min
• Reflecting pool algae: the science Trump needs to know · June 30, 2026 · 16 min

Explore listener stats, chart rankings, contacts and more on the Science Weekly podcast page.